14 results
PRE 14A
SYRS
Syros Pharmaceuticals Inc.
12 Apr 24
Preliminary proxy
4:30pm
, 2024)
Board Size:
Total Number of Directors
Female
Male
Non-binary
Did not Disclose Gender
Gender:
Directors
Number of Directors who identify … into consideration the diversity (for example, with respect to gender, race and national origin) of our board members. The nominating and corporate governance
424B3
SYRS
Syros Pharmaceuticals Inc.
8 Aug 22
Prospectus supplement
5:47pm
to report their board composition and/or mandating gender diversity, including New York and California. Tyme has included consistent, transparent
S-4
SYRS
Syros Pharmaceuticals Inc.
18 Jul 22
Registration of securities issued in business combination transactions
7:58am
of states are requiring organizations to report their board composition and/or mandating gender diversity, including New York and California. Tyme has
8-K
EX-99.1
yujya22 os0qi1r5zu4
20 Sep 21
Regulation FD Disclosure
4:02pm
8-K
EX-10.1
gcaydcqg5 u413jfp
11 Jan 19
Entry into a Material Definitive Agreement
5:02pm
- Prev
- 1
- Next